Showing results (111-120 of 160) with videos related to

Sort By:
Pageof 16
Oncotarget|March 24, 2018
Leukocyte telomere length throughout the continuum of colorectal carcinogenesisCornelia Zöchmeister, Stefanie Brezina, Philipp Hofer, et al.
International Journal of Molecular Sciences|December 6, 2016
Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer CellsAnna-Maria Pehserl, Anna Lena Ress, Stefanie Stanzer, et al.
Anticancer Research|November 2, 2010
Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study)Wu Zhang, Mizutomo Azuma, Georg Lurje, et al.
Plos One|November 14, 2013
External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patientsJoanna Szkandera, Michael Stotz, Florian Eisner, et al.
Therapeutic Advances in Medical Oncology|August 9, 2021
Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy: a single-centre experienceSusanne Scheipl, Iva Brcic, Tina Moser, et al.
Molecular Cancer Therapeutics|October 31, 2013
Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapyYan Ning, Armin Gerger, Wu Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Influence of sex on the survival of patients with esophageal cancerPierre Bohanes, Dongyun Yang, Ruchika S Chhibar, et al.
Scientific Reports|July 26, 2020
Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patientsAdrian Stelzl, Faisal Aziz, Jakob M Riedl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
Common cancer stem cell gene variants predict colon cancer recurrenceArmin Gerger, Wu Zhang, Dongyun Yang, et al.
Therapeutic Advances in Medical Oncology|October 7, 2021
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysisMoritz Müller, Florian Posch, Dominik Kiem, et al.
Pageof 16